Literature DB >> 7737714

Trends in medication choices for hypertension in the elderly. The decline of the thiazides.

M Monane1, R J Glynn, J H Gurwitz, R L Bohn, R Levin, J Avorn.   

Abstract

We studied the evolution in choice of antihypertensive therapy in the elderly over a seven-year period and defined factors associated with such prescribing. To accomplish this, we performed a retrospective analysis of 8428 enrollees older than 65 years of age in the New Jersey Medicaid and Medicare programs newly begun on antihypertensive therapy between 1982 and 1988. Diuretics were the most common agents prescribed (51%), followed by calcium channel blockers (14%), beta-blockers (13%), central adrenergic antagonists (11%), and angiotensin-converting enzyme inhibitors (5%). However, the use of diuretics declined sharply during the latter part of the time interval studied. Using logistic regression modeling, we determined that the odds of a subject being started on a diuretic compared with any other antihypertensive drug decreased from 1.0 during the referent years 1982 to 1984 to 0.75 in 1985 to 1986 and to 0.41 in 1987 to 1988, after controlling for demographics, comorbidity, and hospital and physician visits (P < .001). The relative odds of diuretic use were significantly increased (P < .05) for the oldest subjects (odds ratio, 1.28 for age 85 and older versus ages 65 to 74 odds), women (odds ratio, 1.15), and blacks (odds ratio, 1.14). Despite the growing evidence during the study interval of the efficacy of diuretics in treating hypertension in the elderly, diuretic use diminished throughout this period in relation to other antihypertensive drugs. Subject characteristics (oldest subjects, women, and blacks) were important determinants of physicians' choice of antihypertensive therapy.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7737714     DOI: 10.1161/01.hyp.25.5.1045

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  8 in total

Review 1.  Measuring adherence to practice guidelines for the management of hypertension: an evaluation of the literature.

Authors:  Jessica L Milchak; Barry L Carter; Paul A James; Gail Ardery
Journal:  Hypertension       Date:  2004-09-20       Impact factor: 10.190

2.  Development of explicit criteria to measure adherence to hypertension guidelines.

Authors:  J L Milchak; B L Carter; G Ardery; H R Black; G L Bakris; D W Jones; C D Kreiter
Journal:  J Hum Hypertens       Date:  2006-06       Impact factor: 3.012

3.  Use of combination antihypertensive therapy initiation in older Americans without prevalent cardiovascular disease.

Authors:  Xiaojuan Li; Wendy Camelo Castillo; Til Stürmer; Virginia Pate; Christine L Gray; Ross J Simpson; Soko Setoguchi; Laura C Hanson; Michele Jonsson Funk
Journal:  J Am Geriatr Soc       Date:  2014-08-12       Impact factor: 5.562

4.  Compliance with antihypertensive therapy among elderly Medicaid enrollees: the roles of age, gender, and race.

Authors:  M Monane; R L Bohn; J H Gurwitz; R J Glynn; R Levin; J Avorn
Journal:  Am J Public Health       Date:  1996-12       Impact factor: 9.308

5.  Failure of evidence-based medicine in the treatment of hypertension in older patients.

Authors:  E L Knight; R J Glynn; R Levin; D A Ganz; J Avorn
Journal:  J Gen Intern Med       Date:  2000-10       Impact factor: 5.128

6.  Implementation of local guidelines for cost-effective management of hypertension. A trial of the firm system.

Authors:  J N Aucott; E Pelecanos; R Dombrowski; S M Fuehrer; J Laich; D C Aron
Journal:  J Gen Intern Med       Date:  1996-03       Impact factor: 5.128

7.  Explicit and implicit evaluation of physician adherence to hypertension guidelines.

Authors:  Gail Ardery; Barry L Carter; Jessica L Milchak; George R Bergus; Jeffrey D Dawson; Paul A James; Carrie Franciscus; Yoonsang Kim
Journal:  J Clin Hypertens (Greenwich)       Date:  2007-02       Impact factor: 3.738

8.  Physician adherence to hypertension treatment guidelines and drug acquisition costs of antihypertensive drugs at the cardiac clinic: a pilot study.

Authors:  Shaymaa Abdalwahed Abdulameer; Mohanad Naji Sahib; Noorizan Abd Aziz; Yahaya Hassan; Hadeer Akram Abdul Alrazzaq; Omar Ismail
Journal:  Patient Prefer Adherence       Date:  2012-01-31       Impact factor: 2.711

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.